Skip to main content

Meet the Analyst: Dr. Tara Speranza, Bell Potter Analyst Part 2

Grady Wulff
February 23, 2023

Continue on to learn about the remaining stocks, Microba Life Sciences (ASX:MAP) and Monash IVF (ASX:MVF), as well as what to expect from these companies in 2023.

In this video, Dr. Tara discusses:
– (0:34) Impacts of Ferring’s FDA approval on Microba
– (5:30) Drivers behind Microba’s increase in revenue
– (7:12) What 2023 looks like for Monash IVF
– (8:39) Monash IVF’s rating
– (11:45) Monash IVF’s impact from legal action

Note: This interview was filmed on 7 February 2023.

Morning Bell 24 February

Jessica Amir
February 24, 2021

Morning Bell 23 February

Jessica Amir
February 23, 2021

Morning Bell 22 February

Jessica Amir
February 22, 2021

Weekly Wrap 19 February

Jessica Amir
February 19, 2021

Morning Bell 19 February

Jessica Amir
February 19, 2021

Morning Bell 18 February

Jessica Amir
February 18, 2021

Morning Bell 17 February

Jessica Amir
February 17, 2021

Morning Bell 16 February

Jessica Amir
February 16, 2021

Morning Bell 15 February

Jessica Amir
February 15, 2021

Weekly Wrap 12 February

Jessica Amir
February 12, 2021